This miniWEBINAR is presented by Hari Muddana Ph.D., Head of the Physics Group at OpenEye, Cadence Molecular Sciences. Hari is leading the development of Crystal Structure Prediction (CSP) workflows for drug-like molecules and the application of large-scale quantum chemistry calculations in drug development.
About this session
Ensuring the stability of the crystal structure is critical for solid-form development of drugs. OpenEye’s CSP workflow provides a well-validated approach to predicting the crystal form landscape of a molecule, allowing the identification of possible alternative crystal forms (polymorphs) early in the development process. This webinar will cover the latest developments and capabilities of this workflow, including CSP of single and multi-component systems with Z’=1 or 2.
